Nature Communications (Jul 2019)
NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance
Abstract
Improper innate sensing within the tumor microenvironment limits immunotherapy success. Here, the authors show that targeting NQO1 triggers immunogenic innate sensing to reactivate T cells and overcome immune checkpoint blockade resistance.